Home » Topics » BioWorld Science

BioWorld Science
RSS

NeoImmuneTech enters clinical trial collaboration with Roche

May 3, 2018

FDA grants rare pediatric disease designation to CLR-131 for neuroblastoma

May 3, 2018

Millennium Pharmaceuticals initiates first-in-human trial of TAK-164

May 3, 2018

First-in-human study of hepatitis B DNA vaccine JNJ-64300535

May 3, 2018

Enrollment ongoing in phase III trial of enfortumab vedotin for urothelial cancer

May 3, 2018

EMA approves Alpivab for the treatment of influenza

May 3, 2018

YW-1128, a WNT pathway inhibitor, shows promising in vivo results for metabolic disorders

May 3, 2018

Janssen to acquire Benevir Biopharm

May 3, 2018

Merck KGaA and SFJ partner on abituzumab in metastatic colorectal cancer

May 3, 2018

SignalRx discovers selective BRD4-BD1 inhibitor

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...